Signaling Pathways - MK2 - HCV polymerase - NUAK2 - Eph Receptors
清除全部
- B1374 WZ4003Target: NUAK1|NUAK2Summary: NUAK1/2抑制剂
- C5545 MK2 Inhibitor IVTarget: MK2Summary: 高选择性、非ATP竞争性MK2抑制剂
- B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂
- B5549 PF-3644022Target: MK2Summary: MK2抑制剂
- B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
- A8683 NVP-BHG712Target: Eph Receptors|VEGFRSummary: EphB4 抑制剂
- A3738 PSI-7977中文名: 索非布韦,索氟布韦Target: HCV polymeraseSummary: 慢性丙型肝炎病毒(HCV)感染的抗病毒剂
- A3721 PHA-767491Target: Cyclin-Dependent Kinases|MK2|Cdc7Summary: Cdc7 / CDK9抑制剂
- A3165 ALW-II-41-271 CitationTarget: Eph ReceptorsSummary: Eph受体抑制剂
- A4032 VX-222 (VCH-222, Lomibuvir)Target: HCV polymeraseSummary: HCV RNA聚合酶抑制剂